Home » Psychology news » FDA approves first drug to treat tardive dyskinesia
FDA approves first drug to treat tardive dyskinesia
April 12, 2017 by NewsBot
The U.S. Food and Drug Administration has approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia. This is the first drug approved by the FDA for this condition.
